ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ursodeoxycholic Acid Preparations Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-26T12434
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Ursodeoxycholic Acid Preparations Market Research Report 2022
BUY CHAPTERS

Global Ursodeoxycholic Acid Preparations Market Research Report 2025

Code: QYRE-Auto-26T12434
Report
February 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dr. Falk Pharma
Daewoong Pharmaceutical
TEVA
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan NV
Bruschettini
Impax
Shanghai Pharma
Grindeks

Ursodeoxycholic Acid Preparations Market Size

The global market for Ursodeoxycholic Acid Preparations was valued at US$ 1992 million in the year 2024 and is projected to reach a revised size of US$ 4172 million by 2031, growing at a CAGR of 11.3% during the forecast period.

Ursodeoxycholic Acid Preparations Market

Ursodeoxycholic Acid Preparations Market

Ursodeoxycholic acid, whose chemical name is 3a,7β-dihydroxy-5β-cholestane-24-acid, is an organic compound with an odorless, bitter taste. It is used in medicine to increase the secretion of bile acid, change the composition of bile, reduce cholesterol and cholesterol lipid in bile, and help the cholesterol in gallstones to gradually dissolve.
The Ursodeoxycholic Acid (UDCA) drug market is driven by the increasing prevalence of liver and gallbladder disorders and the growing adoption of UDCA as an effective treatment option. UDCA is a naturally occurring bile acid that helps dissolve cholesterol-rich gallstones and aids in the treatment of certain liver diseases, such as primary biliary cholangitis (PBC) and nonalcoholic fatty liver disease (NAFLD). The rise in liver-related conditions and the need for improved therapeutic options contribute to market growth as UDCA offers a well-tolerated and disease-modifying treatment for these disorders. Moreover, advancements in drug formulations and the development of combination therapies have enhanced the efficacy of UDCA treatment. However, the market also faces challenges, including the cost of UDCA drugs and the need for further research to optimize dosing and treatment protocols. Additionally, addressing regulatory requirements and ensuring accessibility to patients can pose obstacles for broader adoption. To succeed, companies must focus on research and development to offer innovative and affordable UDCA drugs, collaborate with hepatologists to optimize treatment approaches, and address the challenges to meet the increasing demand for effective and well-tolerated therapeutic options for liver and gallbladder disorders.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ursodeoxycholic Acid Preparations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ursodeoxycholic Acid Preparations.
The Ursodeoxycholic Acid Preparations market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ursodeoxycholic Acid Preparations market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ursodeoxycholic Acid Preparations manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ursodeoxycholic Acid Preparations Market Report

Report Metric Details
Report Name Ursodeoxycholic Acid Preparations Market
Accounted market size in year US$ 1992 million
Forecasted market size in 2031 US$ 4172 million
CAGR 11.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tablet
  • Capsule
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Mylan, Bruschettini, Impax, Shanghai Pharma, Grindeks
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ursodeoxycholic Acid Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ursodeoxycholic Acid Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Ursodeoxycholic Acid Preparations Market growing?

Ans: The Ursodeoxycholic Acid Preparations Market witnessing a CAGR of 11.3% during the forecast period 2025-2031.

What is the Ursodeoxycholic Acid Preparations Market size in 2031?

Ans: The Ursodeoxycholic Acid Preparations Market size in 2031 will be US$ 4172 million.

Who are the main players in the Ursodeoxycholic Acid Preparations Market report?

Ans: The main players in the Ursodeoxycholic Acid Preparations Market are Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Mylan, Bruschettini, Impax, Shanghai Pharma, Grindeks

What are the Application segmentation covered in the Ursodeoxycholic Acid Preparations Market report?

Ans: The Applications covered in the Ursodeoxycholic Acid Preparations Market report are Gallstones, Liver Disease, Stomach Trouble, Other

What are the Type segmentation covered in the Ursodeoxycholic Acid Preparations Market report?

Ans: The Types covered in the Ursodeoxycholic Acid Preparations Market report are Tablet, Capsule

Recommended Reports

Bile Acid Markets

Liver Disease Therapy

Biliary Disease Treatments

1 Ursodeoxycholic Acid Preparations Market Overview
1.1 Product Definition
1.2 Ursodeoxycholic Acid Preparations by Type
1.2.1 Global Ursodeoxycholic Acid Preparations Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.3 Ursodeoxycholic Acid Preparations by Application
1.3.1 Global Ursodeoxycholic Acid Preparations Market Value by Application (2024 VS 2031)
1.3.2 Gallstones
1.3.3 Liver Disease
1.3.4 Stomach Trouble
1.3.5 Other
1.4 Global Ursodeoxycholic Acid Preparations Market Size Estimates and Forecasts
1.4.1 Global Ursodeoxycholic Acid Preparations Revenue 2020-2031
1.4.2 Global Ursodeoxycholic Acid Preparations Sales 2020-2031
1.4.3 Global Ursodeoxycholic Acid Preparations Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ursodeoxycholic Acid Preparations Market Competition by Manufacturers
2.1 Global Ursodeoxycholic Acid Preparations Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ursodeoxycholic Acid Preparations Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ursodeoxycholic Acid Preparations Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ursodeoxycholic Acid Preparations, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ursodeoxycholic Acid Preparations, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ursodeoxycholic Acid Preparations, Product Type & Application
2.7 Global Key Manufacturers of Ursodeoxycholic Acid Preparations, Date of Enter into This Industry
2.8 Global Ursodeoxycholic Acid Preparations Market Competitive Situation and Trends
2.8.1 Global Ursodeoxycholic Acid Preparations Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ursodeoxycholic Acid Preparations Players Market Share by Revenue
2.8.3 Global Ursodeoxycholic Acid Preparations Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ursodeoxycholic Acid Preparations Market Scenario by Region
3.1 Global Ursodeoxycholic Acid Preparations Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ursodeoxycholic Acid Preparations Sales by Region: 2020-2031
3.2.1 Global Ursodeoxycholic Acid Preparations Sales by Region: 2020-2025
3.2.2 Global Ursodeoxycholic Acid Preparations Sales by Region: 2026-2031
3.3 Global Ursodeoxycholic Acid Preparations Revenue by Region: 2020-2031
3.3.1 Global Ursodeoxycholic Acid Preparations Revenue by Region: 2020-2025
3.3.2 Global Ursodeoxycholic Acid Preparations Revenue by Region: 2026-2031
3.4 North America Ursodeoxycholic Acid Preparations Market Facts & Figures by Country
3.4.1 North America Ursodeoxycholic Acid Preparations Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ursodeoxycholic Acid Preparations Sales by Country (2020-2031)
3.4.3 North America Ursodeoxycholic Acid Preparations Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ursodeoxycholic Acid Preparations Market Facts & Figures by Country
3.5.1 Europe Ursodeoxycholic Acid Preparations Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ursodeoxycholic Acid Preparations Sales by Country (2020-2031)
3.5.3 Europe Ursodeoxycholic Acid Preparations Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ursodeoxycholic Acid Preparations Market Facts & Figures by Region
3.6.1 Asia Pacific Ursodeoxycholic Acid Preparations Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ursodeoxycholic Acid Preparations Sales by Region (2020-2031)
3.6.3 Asia Pacific Ursodeoxycholic Acid Preparations Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ursodeoxycholic Acid Preparations Market Facts & Figures by Country
3.7.1 Latin America Ursodeoxycholic Acid Preparations Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ursodeoxycholic Acid Preparations Sales by Country (2020-2031)
3.7.3 Latin America Ursodeoxycholic Acid Preparations Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ursodeoxycholic Acid Preparations Market Facts & Figures by Country
3.8.1 Middle East and Africa Ursodeoxycholic Acid Preparations Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ursodeoxycholic Acid Preparations Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ursodeoxycholic Acid Preparations Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ursodeoxycholic Acid Preparations Sales by Type (2020-2031)
4.1.1 Global Ursodeoxycholic Acid Preparations Sales by Type (2020-2025)
4.1.2 Global Ursodeoxycholic Acid Preparations Sales by Type (2026-2031)
4.1.3 Global Ursodeoxycholic Acid Preparations Sales Market Share by Type (2020-2031)
4.2 Global Ursodeoxycholic Acid Preparations Revenue by Type (2020-2031)
4.2.1 Global Ursodeoxycholic Acid Preparations Revenue by Type (2020-2025)
4.2.2 Global Ursodeoxycholic Acid Preparations Revenue by Type (2026-2031)
4.2.3 Global Ursodeoxycholic Acid Preparations Revenue Market Share by Type (2020-2031)
4.3 Global Ursodeoxycholic Acid Preparations Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ursodeoxycholic Acid Preparations Sales by Application (2020-2031)
5.1.1 Global Ursodeoxycholic Acid Preparations Sales by Application (2020-2025)
5.1.2 Global Ursodeoxycholic Acid Preparations Sales by Application (2026-2031)
5.1.3 Global Ursodeoxycholic Acid Preparations Sales Market Share by Application (2020-2031)
5.2 Global Ursodeoxycholic Acid Preparations Revenue by Application (2020-2031)
5.2.1 Global Ursodeoxycholic Acid Preparations Revenue by Application (2020-2025)
5.2.2 Global Ursodeoxycholic Acid Preparations Revenue by Application (2026-2031)
5.2.3 Global Ursodeoxycholic Acid Preparations Revenue Market Share by Application (2020-2031)
5.3 Global Ursodeoxycholic Acid Preparations Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dr. Falk Pharma
6.1.1 Dr. Falk Pharma Company Information
6.1.2 Dr. Falk Pharma Description and Business Overview
6.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dr. Falk Pharma Ursodeoxycholic Acid Preparations Product Portfolio
6.1.5 Dr. Falk Pharma Recent Developments/Updates
6.2 Daewoong Pharmaceutical
6.2.1 Daewoong Pharmaceutical Company Information
6.2.2 Daewoong Pharmaceutical Description and Business Overview
6.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daewoong Pharmaceutical Ursodeoxycholic Acid Preparations Product Portfolio
6.2.5 Daewoong Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Ursodeoxycholic Acid Preparations Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Epic Pharma
6.4.1 Epic Pharma Company Information
6.4.2 Epic Pharma Description and Business Overview
6.4.3 Epic Pharma Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Epic Pharma Ursodeoxycholic Acid Preparations Product Portfolio
6.4.5 Epic Pharma Recent Developments/Updates
6.5 Mitsubishi Tanabe Pharma
6.5.1 Mitsubishi Tanabe Pharma Company Information
6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Preparations Product Portfolio
6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Company Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lannett Ursodeoxycholic Acid Preparations Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Ursodeoxycholic Acid Preparations Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Bruschettini
6.8.1 Bruschettini Company Information
6.8.2 Bruschettini Description and Business Overview
6.8.3 Bruschettini Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bruschettini Ursodeoxycholic Acid Preparations Product Portfolio
6.8.5 Bruschettini Recent Developments/Updates
6.9 Impax
6.9.1 Impax Company Information
6.9.2 Impax Description and Business Overview
6.9.3 Impax Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Impax Ursodeoxycholic Acid Preparations Product Portfolio
6.9.5 Impax Recent Developments/Updates
6.10 Shanghai Pharma
6.10.1 Shanghai Pharma Company Information
6.10.2 Shanghai Pharma Description and Business Overview
6.10.3 Shanghai Pharma Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai Pharma Ursodeoxycholic Acid Preparations Product Portfolio
6.10.5 Shanghai Pharma Recent Developments/Updates
6.11 Grindeks
6.11.1 Grindeks Company Information
6.11.2 Grindeks Description and Business Overview
6.11.3 Grindeks Ursodeoxycholic Acid Preparations Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Grindeks Ursodeoxycholic Acid Preparations Product Portfolio
6.11.5 Grindeks Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ursodeoxycholic Acid Preparations Industry Chain Analysis
7.2 Ursodeoxycholic Acid Preparations Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ursodeoxycholic Acid Preparations Production Mode & Process Analysis
7.4 Ursodeoxycholic Acid Preparations Sales and Marketing
7.4.1 Ursodeoxycholic Acid Preparations Sales Channels
7.4.2 Ursodeoxycholic Acid Preparations Distributors
7.5 Ursodeoxycholic Acid Preparations Customer Analysis
8 Ursodeoxycholic Acid Preparations Market Dynamics
8.1 Ursodeoxycholic Acid Preparations Industry Trends
8.2 Ursodeoxycholic Acid Preparations Market Drivers
8.3 Ursodeoxycholic Acid Preparations Market Challenges
8.4 Ursodeoxycholic Acid Preparations Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Dr. Falk Pharma
Daewoong Pharmaceutical
TEVA
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan NV
Bruschettini
Impax
Shanghai Pharma
Grindeks
List of Tables
 Table 1. Global Ursodeoxycholic Acid Preparations Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ursodeoxycholic Acid Preparations Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ursodeoxycholic Acid Preparations Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ursodeoxycholic Acid Preparations Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ursodeoxycholic Acid Preparations Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ursodeoxycholic Acid Preparations Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ursodeoxycholic Acid Preparations Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ursodeoxycholic Acid Preparations Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ursodeoxycholic Acid Preparations, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ursodeoxycholic Acid Preparations, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ursodeoxycholic Acid Preparations, Product Type & Application
 Table 12. Global Key Manufacturers of Ursodeoxycholic Acid Preparations, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ursodeoxycholic Acid Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ursodeoxycholic Acid Preparations as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ursodeoxycholic Acid Preparations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ursodeoxycholic Acid Preparations Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ursodeoxycholic Acid Preparations Sales Market Share by Region (2020-2025)
 Table 19. Global Ursodeoxycholic Acid Preparations Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ursodeoxycholic Acid Preparations Sales Market Share by Region (2026-2031)
 Table 21. Global Ursodeoxycholic Acid Preparations Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ursodeoxycholic Acid Preparations Revenue Market Share by Region (2020-2025)
 Table 23. Global Ursodeoxycholic Acid Preparations Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ursodeoxycholic Acid Preparations Revenue Market Share by Region (2026-2031)
 Table 25. North America Ursodeoxycholic Acid Preparations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ursodeoxycholic Acid Preparations Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ursodeoxycholic Acid Preparations Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ursodeoxycholic Acid Preparations Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ursodeoxycholic Acid Preparations Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ursodeoxycholic Acid Preparations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ursodeoxycholic Acid Preparations Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ursodeoxycholic Acid Preparations Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ursodeoxycholic Acid Preparations Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ursodeoxycholic Acid Preparations Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ursodeoxycholic Acid Preparations Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ursodeoxycholic Acid Preparations Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ursodeoxycholic Acid Preparations Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ursodeoxycholic Acid Preparations Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ursodeoxycholic Acid Preparations Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ursodeoxycholic Acid Preparations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ursodeoxycholic Acid Preparations Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ursodeoxycholic Acid Preparations Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ursodeoxycholic Acid Preparations Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ursodeoxycholic Acid Preparations Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ursodeoxycholic Acid Preparations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ursodeoxycholic Acid Preparations Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ursodeoxycholic Acid Preparations Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ursodeoxycholic Acid Preparations Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ursodeoxycholic Acid Preparations Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ursodeoxycholic Acid Preparations Sales (K Units) by Type (2020-2025)
 Table 51. Global Ursodeoxycholic Acid Preparations Sales (K Units) by Type (2026-2031)
 Table 52. Global Ursodeoxycholic Acid Preparations Sales Market Share by Type (2020-2025)
 Table 53. Global Ursodeoxycholic Acid Preparations Sales Market Share by Type (2026-2031)
 Table 54. Global Ursodeoxycholic Acid Preparations Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ursodeoxycholic Acid Preparations Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ursodeoxycholic Acid Preparations Revenue Market Share by Type (2020-2025)
 Table 57. Global Ursodeoxycholic Acid Preparations Revenue Market Share by Type (2026-2031)
 Table 58. Global Ursodeoxycholic Acid Preparations Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ursodeoxycholic Acid Preparations Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ursodeoxycholic Acid Preparations Sales (K Units) by Application (2020-2025)
 Table 61. Global Ursodeoxycholic Acid Preparations Sales (K Units) by Application (2026-2031)
 Table 62. Global Ursodeoxycholic Acid Preparations Sales Market Share by Application (2020-2025)
 Table 63. Global Ursodeoxycholic Acid Preparations Sales Market Share by Application (2026-2031)
 Table 64. Global Ursodeoxycholic Acid Preparations Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ursodeoxycholic Acid Preparations Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ursodeoxycholic Acid Preparations Revenue Market Share by Application (2020-2025)
 Table 67. Global Ursodeoxycholic Acid Preparations Revenue Market Share by Application (2026-2031)
 Table 68. Global Ursodeoxycholic Acid Preparations Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ursodeoxycholic Acid Preparations Price (US$/Unit) by Application (2026-2031)
 Table 70. Dr. Falk Pharma Company Information
 Table 71. Dr. Falk Pharma Description and Business Overview
 Table 72. Dr. Falk Pharma Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Dr. Falk Pharma Ursodeoxycholic Acid Preparations Product
 Table 74. Dr. Falk Pharma Recent Developments/Updates
 Table 75. Daewoong Pharmaceutical Company Information
 Table 76. Daewoong Pharmaceutical Description and Business Overview
 Table 77. Daewoong Pharmaceutical Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Daewoong Pharmaceutical Ursodeoxycholic Acid Preparations Product
 Table 79. Daewoong Pharmaceutical Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teva Ursodeoxycholic Acid Preparations Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Epic Pharma Company Information
 Table 86. Epic Pharma Description and Business Overview
 Table 87. Epic Pharma Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Epic Pharma Ursodeoxycholic Acid Preparations Product
 Table 89. Epic Pharma Recent Developments/Updates
 Table 90. Mitsubishi Tanabe Pharma Company Information
 Table 91. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 92. Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Preparations Product
 Table 94. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 95. Lannett Company Information
 Table 96. Lannett Description and Business Overview
 Table 97. Lannett Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lannett Ursodeoxycholic Acid Preparations Product
 Table 99. Lannett Recent Developments/Updates
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Ursodeoxycholic Acid Preparations Product
 Table 104. Mylan Recent Developments/Updates
 Table 105. Bruschettini Company Information
 Table 106. Bruschettini Description and Business Overview
 Table 107. Bruschettini Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bruschettini Ursodeoxycholic Acid Preparations Product
 Table 109. Bruschettini Recent Developments/Updates
 Table 110. Impax Company Information
 Table 111. Impax Description and Business Overview
 Table 112. Impax Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Impax Ursodeoxycholic Acid Preparations Product
 Table 114. Impax Recent Developments/Updates
 Table 115. Shanghai Pharma Company Information
 Table 116. Shanghai Pharma Description and Business Overview
 Table 117. Shanghai Pharma Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai Pharma Ursodeoxycholic Acid Preparations Product
 Table 119. Shanghai Pharma Recent Developments/Updates
 Table 120. Grindeks Company Information
 Table 121. Grindeks Description and Business Overview
 Table 122. Grindeks Ursodeoxycholic Acid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Grindeks Ursodeoxycholic Acid Preparations Product
 Table 124. Grindeks Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Ursodeoxycholic Acid Preparations Distributors List
 Table 128. Ursodeoxycholic Acid Preparations Customers List
 Table 129. Ursodeoxycholic Acid Preparations Market Trends
 Table 130. Ursodeoxycholic Acid Preparations Market Drivers
 Table 131. Ursodeoxycholic Acid Preparations Market Challenges
 Table 132. Ursodeoxycholic Acid Preparations Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ursodeoxycholic Acid Preparations
 Figure 2. Global Ursodeoxycholic Acid Preparations Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ursodeoxycholic Acid Preparations Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Global Ursodeoxycholic Acid Preparations Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Ursodeoxycholic Acid Preparations Market Share by Application: 2024 & 2031
 Figure 8. Gallstones
 Figure 9. Liver Disease
 Figure 10. Stomach Trouble
 Figure 11. Other
 Figure 12. Global Ursodeoxycholic Acid Preparations Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Ursodeoxycholic Acid Preparations Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Ursodeoxycholic Acid Preparations Sales (2020-2031) & (K Units)
 Figure 15. Global Ursodeoxycholic Acid Preparations Average Price (US$/Unit) & (2020-2031)
 Figure 16. Ursodeoxycholic Acid Preparations Report Years Considered
 Figure 17. Ursodeoxycholic Acid Preparations Sales Share by Manufacturers in 2024
 Figure 18. Global Ursodeoxycholic Acid Preparations Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Ursodeoxycholic Acid Preparations Players: Market Share by Revenue in Ursodeoxycholic Acid Preparations in 2024
 Figure 20. Ursodeoxycholic Acid Preparations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Ursodeoxycholic Acid Preparations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Ursodeoxycholic Acid Preparations Sales Market Share by Country (2020-2031)
 Figure 23. North America Ursodeoxycholic Acid Preparations Revenue Market Share by Country (2020-2031)
 Figure 24. United States Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Ursodeoxycholic Acid Preparations Sales Market Share by Country (2020-2031)
 Figure 27. Europe Ursodeoxycholic Acid Preparations Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Ursodeoxycholic Acid Preparations Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Ursodeoxycholic Acid Preparations Revenue Market Share by Region (2020-2031)
 Figure 35. China Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Ursodeoxycholic Acid Preparations Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Ursodeoxycholic Acid Preparations Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Ursodeoxycholic Acid Preparations Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Ursodeoxycholic Acid Preparations Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Ursodeoxycholic Acid Preparations Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Ursodeoxycholic Acid Preparations by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Ursodeoxycholic Acid Preparations by Type (2020-2031)
 Figure 54. Global Ursodeoxycholic Acid Preparations Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Ursodeoxycholic Acid Preparations by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Ursodeoxycholic Acid Preparations by Application (2020-2031)
 Figure 57. Global Ursodeoxycholic Acid Preparations Price (US$/Unit) by Application (2020-2031)
 Figure 58. Ursodeoxycholic Acid Preparations Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Oral Ursodeoxycholic Acid Market Research Report 2025
Global Ursodeoxycholic Acid Drug Market Research Report 2024
Drugs of Ursodeoxycholic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global FDF of UDCA and t UDCA Market Research Report 2025
Drugs of UDCA and t UDCA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ursodiol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyodeoxycholic Acid Market Research Report 2025
Global Ursodiol API Market Research Report 2025
Global Ursodeoxycholic Acid Capsules Market Research Report 2024
Global Chenodeoxycholic Acid Market Research Report 2024
Global Sodium Deoxycholate Market Research Report 2025
Global Bile Acid Market Insights Forecast to 2030
Global Lithocholic Acid Market Research Report 2025
Global Chenodeoxycholic Acid API Market Research Report 2024
Global Glycocholic Acid Market Research Report 2025
Global Sodium Taurochenodeoxycholate Market Research Report 2024
Global Deoxycholic Acid Market Research Report 2024
Drugs of UDCA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sodium Taurocholate Market Research Report 2024
Global T UDCA Market Research Report 2025

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions